BURGESS ERNEST G III - 10 Aug 2022 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Ernest G. Burgesss III
Issuer symbol
NHC
Transactions as of
10 Aug 2022
Net transactions value
+$154,750
Form type
4
Filing time
11 Aug 2022, 10:49:02 UTC
Previous filing
06 May 2022
Next filing
07 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $154,750 +2,500 +2.7% $61.90 94,144 10 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,500 -33% $0.000000 5,000 10 Aug 2022 Common Stock 7,500 $61.90 Direct
holding NHC Option to Purchase Common Stock 7,500 10 Aug 2022 Common Stock 7,500 $72.92 Direct
holding NHC Option to Purchase Common Stock 7,500 10 Aug 2022 Common Stock 7,500 $77.92 Direct
holding NHC Option to Purchase Common Stock 7,500 10 Aug 2022 Common Stock 7,500 $64.64 Direct
holding NHC Option to Purchase Common Stock 7,500 10 Aug 2022 Common Stock 7,500 $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7,500 10 Aug 2022 Common Stock 7,500 $69.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).